<DOC>
	<DOCNO>NCT00816452</DOCNO>
	<brief_summary>Patients prostate cancer treat outpatient clinic recruit urologist physician . Primary Objective : To evaluate compliance male patient prostate cancer treat Bisphosphonate suffer Osteopenia/osteoporosis . Secondary objective : To evaluate compliance family physicians prescribe Bisphosphonate patient upon recommendation Urologists . To evaluate overall number patient treated Bisphosphonate out-patient clinic , To evaluate incidence osteopenia/osteoporosis study population .</brief_summary>
	<brief_title>Awareness Osteopenia 's Treatment Bisphosphonate Male Suffering From Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Man Prostate Cancer Men ≥70 year old ≥60 year old treat LHRH agonist least 2 year Man diagnose past Osteopenia/osteoporosis Osteopenia/osteoporosis proven bone density test . Creatinine clearance &lt; 30ml/min Hypercalcemia Actual treatment Bisphosphonate steroid Hypersensibility Bisphosphonate contraindication use . Metastatic prostate Cancer Patients suitable compliance . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Osteoporosis male Prostate Cancer</keyword>
</DOC>